Cargando…
Induced differentiation of acute myeloid leukemia cells by activation of Retinoid X and Liver X Receptors
Use of all-trans-retinoic acid (ATRA) as a differentiation agent has been limited to acute promyelocytic leukemia (APL) as non-APL leukemias are insensitive to ATRA. We recently demonstrated that the rexinoid, bexarotene, induces differentiation and therapeutic responses in patients with refractory...
Autores principales: | Sanchez, Patricia V., Glantz, Spencer T., Scotland, Sarah, Kasner, Margaret T., Carroll, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835482/ https://www.ncbi.nlm.nih.gov/pubmed/23823656 http://dx.doi.org/10.1038/leu.2013.202 |
Ejemplares similares
-
Of Retinoids and Organotins: The Evolution of the Retinoid X Receptor in Metazoa
por: Fonseca, Elza, et al.
Publicado: (2020) -
Retinoid X Receptor Antagonists
por: Watanabe, Masaki, et al.
Publicado: (2018) -
Retinoid Differentiation Therapy for Common Types of Acute Myeloid Leukemia
por: Brown, Geoffrey, et al.
Publicado: (2012) -
Retinoic Acid and Retinoid X Receptors
por: Schubert, Michael, et al.
Publicado: (2023) -
Retinoid X Receptors Intersect the Molecular Clockwork in the Regulation of Liver Metabolism
por: De Cosmo, Salvatore, et al.
Publicado: (2017)